PIK3CA-related Overgrowth Spectrum
Oncology
2 drugs in development·2 companies·1 clinical trial
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| RLY-2608 | Relay Therapeutics, Inc. (RLAY) |
Phase 4(1)
| Drug | Company |
|---|---|
| Alpelisib | Novartis AG (NVS) |
Compare drugs
Frequently asked questions
How many drugs are in development for PIK3CA-related Overgrowth Spectrum?
BioSniper tracks 2 drugs in development for PIK3CA-related Overgrowth Spectrum across 2 companies.
How many clinical trials target PIK3CA-related Overgrowth Spectrum?
There are 1 clinical trial targeting PIK3CA-related Overgrowth Spectrum tracked by BioSniper.
Deep-dive into PIK3CA-related Overgrowth Spectrum
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis